Submit Deal

RENEO PHARMACEUTICALS

Summary

Reneo Pharmaceuticals was a clinical-stage company focused on developing therapies for rare genetic mitochondrial diseases and orphan metabolic diseases.

Deals Overview

Total Deals1

Valued Deals0

Total Value-

Avg. Deal Size-

Market Context

Senior Management

Mike Grey
Executive Chairman and Founder

Sort

13 May 2024|United States|Pharmaceuticals

Target: ONKURE THERAPEUTICS

Bidder: RENEO PHARMACEUTICALS

11 Service Providers

3 Target | 8 Bidder

14 Dealmakers

1 Target | 13 Bidder

n/a

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy